Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease

Published:2017-09 Issue:9 Volume:8 Page:e117
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:

Author:

Kadijani Azade Amini,Aghdaei Hamid Asadzadeh,Sorrentino Dario,Mirzaei Alireza,Shahrokh Shabnam,Balaii Hedieh,Nguyen Vu Q,Mays Jessica L,Zali Mohammad Reza

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference28 articles.

1. Mechanisms of disease: pathogenesis of Crohns disease and ulcerative colitis.;Sartor;Nat Clin Pract Gastroenterol Hepatol,2006

2. Loss of response and requirement of infliximab dose intensification in Crohns disease: a review.;Gisbert;Am J Gastroenterol,2009

3. Review article: targeting TNF as a key cytokine in the inflammatory processes of Crohns diseasethe mechanisms of action of infliximab.;Van Deventer;Aliment Pharmacol Ther,1999

4. Review article: causative factors and the clinical management of patients with Crohns disease who lose response to anti-TNF- therapy.;Danese;Aliment Pharmacol Ther,2011

5. Therapeutic drug monitoring and clinical outcomes in immune mediated diseases: the missing link.;Sorrentino;Inflamm Bowel Dis,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study;Frontiers in Pharmacology;2023-10-16

2. Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine;Expert Review of Clinical Immunology;2021-06-28

3. Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation;iScience;2021-04

4. Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab;Clinical Gastroenterology and Hepatology;2021-04

5. Novel bio-genetic predictors of response to biologic treatment in inflammatory bowel diseases;Current Opinion in Pharmacology;2020-12